Skip to main content
. 2019 Mar 19;9:4848. doi: 10.1038/s41598-019-41015-5

Figure 2.

Figure 2

Recurrence scores (RS) of all cancer cohorts, calculated as the fraction of recurrent missense mutations to total missense mutations in the pool. Recurrent mutations were defined as those which exceeded 1% prevalence in the cohort.